These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27830190)

  • 41. Reduced glycerol incorporation into phospholipids contributes to impaired intra-erythrocytic growth of glycerol kinase knockout Plasmodium falciparum parasites.
    Naidoo K; Coetzer TL
    Biochim Biophys Acta; 2013 Nov; 1830(11):5326-34. PubMed ID: 23954205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Malaria, genetics and molecular biology: myths, hopes and realities].
    Ambroise-Thomas P
    Ann Pharm Fr; 2001 Apr; 59(2):93-104. PubMed ID: 11320333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toward forward genetic screens in malaria-causing parasites using the piggyBac transposon.
    Crabb BS; de Koning-Ward TF; Gilson PR
    BMC Biol; 2011 Mar; 9():21. PubMed ID: 21453557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pervasive sequence-level variation in the transcriptome of
    Dave B; Kanyal A; Mamatharani DV; Karmodiya K
    NAR Genom Bioinform; 2022 Jun; 4(2):lqac036. PubMed ID: 35591889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phylogenetic profiles of all membrane transport proteins of the malaria parasite highlight new drug targets.
    Weiner J; Kooij TW
    Microb Cell; 2016 Aug; 3(10):511-521. PubMed ID: 28357319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PhenoPlasm: a database of disruption phenotypes for malaria parasite genes.
    Sanderson T; Rayner JC
    Wellcome Open Res; 2017; 2():45. PubMed ID: 28748223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transforming the CRISPR/dCas9-based gene regulation technique into a forward screening tool in
    Lucky AB; Wang C; Li X; Liang X; Muneer A; Miao J
    iScience; 2024 Apr; 27(4):109602. PubMed ID: 38617559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression of the canonical reference malaria parasite genome from 2002-2019.
    Böhme U; Otto TD; Sanders M; Newbold CI; Berriman M
    Wellcome Open Res; 2019; 4():58. PubMed ID: 31080894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The malaria genome sequencing project.
    Carucci DJ; Gardner MJ; Tettelin H; Cummings LM; Smith HO; Adams MD; Hoffman SL; Venter JC
    Expert Rev Mol Med; 1998 May; 1998():1-9. PubMed ID: 14585131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring Genetic Silencing: RNAi and CRISPR-Cas Potential Against Drug Resistance in Malaria.
    Gaona-Lopez C; Rivera G
    Mini Rev Med Chem; 2024 Jun; ():. PubMed ID: 38932611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotype to genotype using forward-genetic Mu-seq for identification and functional classification of maize mutants.
    Hunter CT; Suzuki M; Saunders J; Wu S; Tasi A; McCarty DR; Koch KE
    Front Plant Sci; 2014 Jan; 4():545. PubMed ID: 24432026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parasite-host interaction in malaria: genetic clues and copy number variation.
    Faik I; de Carvalho EG; Kun JF
    Genome Med; 2009 Sep; 1(9):82. PubMed ID: 19725943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells.
    Horn M; Kroef V; Allmeroth K; Schuller N; Miethe S; Peifer M; Penninger JM; Elling U; Denzel MS
    Oncotarget; 2018 Feb; 9(11):9838-9851. PubMed ID: 29515774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The expanding role of mouse genetics for understanding human biology and disease.
    Nguyen D; Xu T
    Dis Model Mech; 2008; 1(1):56-66. PubMed ID: 19048054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA replication in the malaria parasite.
    White JH; Kilbey BJ
    Parasitol Today; 1996 Apr; 12(4):151-5. PubMed ID: 15275224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for stress-resistance mutations in the mouse.
    Chick WS; Ludwig M; Zhao X; Kitzenberg D; Williams K; Johnson TE
    Front Genet; 2014; 5():310. PubMed ID: 25250048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Finding meaning in chaos: a selection signature for functional interactions and its use in molecular biology.
    Weiner L; Brissette JL
    FEBS J; 2023 Aug; 290(16):3914-3927. PubMed ID: 35653424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accelerating forward genetics for cell wall deconstruction.
    Vidaurre D; Bonetta D
    Front Plant Sci; 2012; 3():119. PubMed ID: 22685448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A modifier screen identifies
    Ding Y; Long PA; Bos JM; Shih YH; Ma X; Sundsbak RS; Chen J; Jiang Y; Zhao L; Hu X; Wang J; Shi Y; Ackerman MJ; Lin X; Ekker SC; Redfield MM; Olson TM; Xu X
    JCI Insight; 2016 Sep; 1(14):. PubMed ID: 27642634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying druggable disease-modifying gene products.
    Dixon SJ; Stockwell BR
    Curr Opin Chem Biol; 2009 Dec; 13(5-6):549-55. PubMed ID: 19740696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.